Synthesis and anti-inflammatory activity evaluation of a novel series of 6-phenoxy-[1,2,4]triazolo[3,4-a]phthalazine-3-carboxamide derivatives.

Guo-Hua Gong,Cheng-Xi Wei,Xue-Jun Jin,Zhe-Shan Quan
DOI: https://doi.org/10.1016/j.bmcl.2016.02.008
IF: 2.94
2016-01-01
Bioorganic & Medicinal Chemistry Letters
Abstract:A new series of anti-inflammatory 6-phenoxy-[1,2,4]triazolo[3,4-a]phthalazine-3-carboxamide derivatives were synthesized and their anti-inflammatory activities were evaluated by the luciferase reporter assay. 6-(3-Tolyloxy)-[1,2,4]triazolo[3,4-a]phthalazine-3-carboxamide (compound 6i) had comparable activity with the reference drug dihydrotanshinone with low cellular toxicity. Then, compound 6i was selected for anti-inflammatory evaluation in vivo. The activity screening indicated that compound 6i at 50mg/kg showed 58.19% inhibition at 0.5h after i.p. and 38.8% inhibition by p.o.
What problem does this paper attempt to address?